Related Experiment Video
Updated: Aug 28, 2026

Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein
Published on: April 21, 2015
Mechanism of human MxA protein action: variants with changed antiviral properties
T Zürcher1, J Pavlovic, P Staeheli
1Institute for Immunology and Virology, University of Zürich, Switzerland.
Abstract:
Cells respond to treatment with interferons by synthesizing several induced proteins, including one or more structurally related proteins collectively called Mx. Nuclear and cytoplasmic forms of Mx have been described, some of which inhibit virus replication. Human MxA is a cytoplasmic protein that specifically inhibits the multiplication of influenza virus and vesicular stomatitis virus. Here, we describe a mutant MxA protein, MxA(R645), which inhibited influenza virus but was inactive against vesicular stomatitis virus. It differs from wild-type MxA by a Glu to Arg substitution near the carboxy terminus. Like wild-type MxA, and as expected for an Mx protein acting in the cytoplasm, MxA(R645) blocked influenza virus at a step after primary transcription. When moved to the nucleus of transfected cells with the help of a foreign nuclear transport signal, its mode of action changed. Like mouse Mx1, nuclear MxA(R645) interfered with primary transcription of influenza virus, which is a nuclear process. Our results thus define an MxA region that determines antiviral specificity and further demonstrate that nuclear forms of MxA can mimic the action of mouse Mx1 whose natural location is the cell nucleus.
Insights
A mutant human MxA protein (MxA(R645)) specifically inhibits influenza virus replication. Its antiviral activity and mechanism depend on cellular location, with nuclear MxA mimicking mouse Mx1 action.
Area of Science:
- Virology
- Cell Biology
- Immunology
Background:
- Interferon treatment induces Mx proteins that inhibit viral replication.
- Human MxA is a cytoplasmic protein inhibiting influenza and vesicular stomatitis viruses.
- Mx proteins can exist in nuclear or cytoplasmic forms with distinct functions.
Purpose of the Study:
- To characterize a mutant human MxA protein (MxA(R645)) with altered antiviral specificity.
- To investigate the effect of cellular localization (cytoplasmic vs. nuclear) on MxA's antiviral mechanism.
- To identify regions of MxA responsible for determining antiviral specificity.
Main Methods:
- Site-directed mutagenesis to create MxA(R645) mutant.
- Transfection of cells with wild-type and mutant MxA constructs.
- Assays to measure inhibition of influenza virus and vesicular stomatitis virus replication.
- Localization studies using nuclear transport signals.
Main Results:
- MxA(R645) inhibited influenza virus but not vesicular stomatitis virus, unlike wild-type MxA.
- In the cytoplasm, MxA(R645) blocked influenza virus post-transcriptionally.
- When localized to the nucleus, MxA(R645) inhibited influenza virus primary transcription, similar to mouse Mx1.
Conclusions:
- A specific region near the MxA carboxy terminus dictates its antiviral specificity.
- Nuclear localization alters MxA's antiviral mechanism, enabling it to inhibit viral transcription.
- Nuclear MxA can functionally mimic nuclear Mx proteins like mouse Mx1.
Related Concept Videos
Viral Mutations
DNA Base Pairing
Leaky Scanning
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors

